Skye Bioscience, Inc.
For the period ended Aug 12, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 12, 2026 · Filed Aug 14, 2026
SKYE$0.99-4.8%Stored close · as of Nov 6, 2026
Contents
EX-99.3 · [Slide 4]
[Slide 4]
I would now like to turn the presentation over to your joint hosts Punit Dhillon, Chief Executive Officer of Skye, and Lisa Anson, Redx’s Chief Executive Officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.